Free Trial

Aravive (ARAV) Insider Trading & Ownership

Aravive logo
$0.04 0.00 (0.00%)
(As of 11/20/2024 ET)

Aravive (NASDAQ:ARAV) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
60.40%
Number Of
Insiders Buying
(Last 3 Years)
0
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$10,448.90
Get ARAV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aravive stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ARAV Insider Buying and Selling by Quarter

Aravive Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/30/2021Amato GiacciaDirectorSell3,245$3.22$10,448.90  
(Data available from 1/1/2013 forward)

ARAV Insider Trading Activity - Frequently Asked Questions

The list of insiders at Aravive includes Amato Giaccia. Learn more on insiders at ARAV.

60.40% of Aravive stock is owned by insiders. Learn more on ARAV's insider holdings.

Aravive Key Executives

  • Dr. Fredric N. Eshelman Pharm.D. (Age 75)
    Executive Chairman
    Compensation: $95k
  • Dr. Jeffrey L. Cleland Ph.D. (Age 59)
    Co-Founder
    Compensation: $669.98k
  • Dr. Joshua Aaron Silverman Ph.D.
    Co-Founder
  • Mr. Marek Ciszewski J.D.
    Vice President of Investor Relations


This page (NASDAQ:ARAV) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners